Abstract: Syringocystadenoma papilliferum and tubular apocrine adenoma are rare benign sweat gland tumors. Syringocystadenoma papilliferum occurs alone or in association with other tumors. Although it is rare, the association of tubular apocrine adenoma with syringocystadenoma papilliferum developing in a sebaceous nevus on the scalp is well documented. However, the co-existence of these two tumors without the background of a sebaceous nevus has not been frequently reported. Syringocystadenoma papilliferum and tubular apocrine adenoma may have a histopathological overlap, but a few cases of a syringocystadenoma papilliferum combined with a tubular apocrine adenoma have been reported. Herein we describe an unusual case of syringocystadenoma papilliferum co-existing with a tubular apocrine adenoma located on the back of a 14-year-old patient in the absence of a pre-existing sebaceous nevus.
INTRODUCTION
Syringocystadenoma papilliferum (SCAP) and tubular apocrine adenoma (TAA) are rare and benign sweat gland tumors. 1 SCAP may occur alone or in association with an organoid nevus (sebaceous nevus). In both instances, it is most often found on the scalp or face, occurring in other locations in only a quarter of cases. It is rarely found on the trunk or limbs and occasionally coexists with other tumors. 2 In some cases, TAA may develop in association with SCAP, which occurs in the superficial portion of the TAA. However, the combination of these two tumors in the absence of a sebaceous nevus and affecting another area other than the scalp has not been frequently described. 2 We report a case of SCAP associated with TAA on the back, in the absence of a preexisting sebaceous nevus, affecting an adolescent patient. The objective of the present report is to emphasize the unusual location and the rare association of these two tumors in the absence of sebaceous nevi. We also emphasize the importance of the differential diagnosis, as well as the adequate treatment of this rare disease.
CASE REPORT
A 14-year-old white male patient, asymtomatic congenital lesion with recent increase in size and sporadic discharge. We observed no recurrence after 4 months of follow-up. The association of SCAP and TAA was first described by
Toribio et al. 4 in 1987. Since then, a few similar cases have been described in the literature, with rare cases described in the absence of a sebaceous nevus and affecting other areas of the body. We found only 12 cases of SCAP associated with TAA in the literature, and only three cases describe the absence of preexisting sebaceous nevi (Table 1) . 1, 3 Histopathologically, SCAP consists of cystic invaginations that project into the dermis and open onto the skin surface through one or more orifices. It consists of a double layer of cells: an inner Ishiko et al. 6 reviewed 19 cases of TAA described in the literature. In 10 of the 19 cases, the tumor was connected to the overlying epidermis, and it was necessary to differentiate the lesion from a SCAP. They described TAA as different from SCAP in some respects:
TAA shows no cystic invaginations extending downwards from the epidermis, absent papillary projections and rare or absent plasmacyte infiltration.
7
Our patient underwent excision of the lesion and has been followed at the service. q 
